Japan clearance for mogamulizumab in PTCL/CTCL

Save

Mogamulizumab targets the CC chemokine receptor 4, which is over-expressed on various types of malignant T-cells including those in PTCL/CTCL, and Kyowa Kirin has developed companion diagnostics for use with the product to identify CCR4-positive…